This financing will support XOCEAN in accelerating the growth of its platform servicing the offshore energy and civil hydrography sectors. It will also help enable the company’s geographic expansion and product innovation efforts to meet the rapidly growing demand for high-quality data solutions across the blue economy. Founded in Ireland in 2017, XOCEAN has revolutionized… Continue reading XOCEAN Secures €115 Million Investment to Accelerate Growth of Its Ocean Data Services Platform
Tag: Morgan
XOCEAN Secures €115 Million Investment to Accelerate Growth of Its Ocean Data Services Platform
This financing will support XOCEAN in accelerating the growth of its platform servicing the offshore energy and civil hydrography sectors. It will also help enable the company’s geographic expansion and product innovation efforts to meet the rapidly growing demand for high-quality data solutions across the blue economy. Founded in Ireland in 2017, XOCEAN has revolutionized… Continue reading XOCEAN Secures €115 Million Investment to Accelerate Growth of Its Ocean Data Services Platform
Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference
CARLSBAD, Calif., Jan. 8, 2025 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference at 10:30 a.m. PT on Wednesday, January 15, 2025. A live webcast of the presentation can be accessed on the… Continue reading Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference
ESTUARY POWER CLOSES FINANCING OF ESCAPE SOLAR AND STORAGE PROJECT
RENO, Nev., Jan. 8, 2025 /PRNewswire/ — Estuary Power closed a $340 million financing package for its Escape Solar and Storage project in Lincoln County, Nevada in late December 2024. Escape exemplifies Estuary’s ability to develop complex, innovative projects that create value for multiple stakeholders. Escape includes 185 megawatts (“MW”) of solar photovoltaic capacity and… Continue reading ESTUARY POWER CLOSES FINANCING OF ESCAPE SOLAR AND STORAGE PROJECT
Qualified Health Launches with $30M Seed Funding to Develop the Infrastructure for Generative AI in Healthcare
PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ — Qualified Health today announced its launch with $30 million in seed funding to develop the infrastructure for generative AI in healthcare. The major investors are SignalFire, Healthier Capital, Town Hall Ventures, and Frist Cressey Ventures, along with participation from Intermountain Ventures, Flare Capital Partners, and prominent healthcare… Continue reading Qualified Health Launches with $30M Seed Funding to Develop the Infrastructure for Generative AI in Healthcare
QDOBA Kicks Off 2025 with Planned New Franchise Development Agreements across the U.S.
Cafua Management Leads Expansion with 20 New Restaurants in New Hampshire and Rhode Island SAN DIEGO, Jan. 8, 2025 /PRNewswire/ — QDOBA, America’s #2 restaurant brand in the Mexican fast-casual category, is starting 2025 with several new franchise development agreements to expand its footprint in key U.S. markets. Among these is a significant deal with… Continue reading QDOBA Kicks Off 2025 with Planned New Franchise Development Agreements across the U.S.
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 8, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company’s president and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 8:15 a.m.… Continue reading Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Former Head of Global R&D at Bayer AG and an exceptional leader with a wealth of experience across biopharma Pivotal time of transition as the company prepares to start clinical development of its first-in-class lead candidate, AT-7687 in obesity AT-7687 offers a new mechanism of action, to set a new standard in obesity management COPENHAGEN,… Continue reading Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Kimbell Royalty Partners, LP Announces Pricing of Upsized Public Offering of Common Units
FORT WORTH, Texas, Jan. 7, 2025 /PRNewswire/ — Kimbell Royalty Partners, LP (NYSE: KRP) (“Kimbell”) today announced the pricing of its upsized public offering of 10,000,000 common units representing limited partner interests, at a public offering price of $14.90 per common unit. The total gross proceeds of the offering, before underwriters’ discounts and estimated offering… Continue reading Kimbell Royalty Partners, LP Announces Pricing of Upsized Public Offering of Common Units
Envista Announces Participation in 43rd Annual J.P. Morgan Healthcare Conference
BREA, Calif., Jan. 7, 2025 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in a presentation at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. There will be an… Continue reading Envista Announces Participation in 43rd Annual J.P. Morgan Healthcare Conference